GH Research (GHRS) Other Working Capital Changes (2023 - 2026)
GH Research (GHRS) posted quarterly Other Working Capital Changes of -$66000.0 for Q4 2025, up 40.54% year-over-year from -$46961.5 in Q4 2024, and down 320.0% quarter-over-quarter from $30000.0 in Q3 2025.
Powered by 
Analysis
GH Research (GHRS) Other Working Capital Changes (2023 - 2026) Analysis & Trends
GH Research's Other Working Capital Changes history runs 4 years deep, the most recent figure standing at -$66000.0 for Q4 2025.
- In Q4 2025, Other Working Capital Changes rose 40.54% year-over-year to -$66000.0; the TTM figure through Dec 2025 stood at -$4000.0 (up 97.59% YoY), while the FY2025 annual figure was $42000.0, down 36.36% from the prior year.
- Other Working Capital Changes for Q4 2025 stood at -$66000.0, down from $30000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $217000.0 in Q2 2023, with the low at -$111000.0 in Q4 2024.
- The 4-year median for Other Working Capital Changes is -$2000.0 (2023), against an average of $26769.2.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes slumped 5450.0% in 2024, then soared 1600.0% in 2025.
- GH Research's Other Working Capital Changes stood at $121000.0 in 2022, then slumped by 101.65% to -$2000.0 in 2023, then plunged by 5450.0% to -$111000.0 in 2024, then jumped by 40.54% to -$66000.0 in 2025.
- Business Quant data shows GHRS's Other Working Capital Changes at -$66000.0 in Q4 2025, $30000.0 in Q3 2025, and $13000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | GH Research | 1.72 Bn | 1.36 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -71,000.00 |
| Jun 30, 2026 | -71,000.00 |
| Mar 31, 2026 | -70,000.00 |
| Mar 31, 2026 | -70,000.00 |
| Dec 31, 2025 | -68,000.00 |
| Dec 31, 2025 | -68,000.00 |
| Sep 30, 2025 | -66,000.00 |
| Sep 30, 2025 | -66,000.00 |
| Jun 30, 2025 | -63,000.00 |
| Jun 30, 2025 | -63,000.00 |
| Dec 31, 2024 | -59,000.00 |
| Dec 31, 2024 | -59,000.00 |
| Sep 30, 2024 | -60,000.00 |
| Sep 30, 2024 | -60,000.00 |
| Jun 30, 2024 | -114,000.00 |
| Jun 30, 2024 | -114,000.00 |
| Mar 31, 2024 | -71,000.00 |
| Mar 31, 2024 | -71,000.00 |
| Dec 31, 2023 | -56,000.00 |
| Dec 31, 2023 | -56,000.00 |